GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCC
Authors:
- Tiffany Ching-Yun YuTYTiffany Ching-Yun Yu
- Luqing ZhaoLZLuqing Zhao
- Karen Man-Fong SzeKSKaren Man-Fong Sze
- Lu TianLTLu Tian
- Vanilla Xin ZhangVZVanilla Xin Zhang
- Eva LeeELEva Lee
- Charles Shing KamCKCharles Shing Kam
- Joyce Man-Fong LeeJLJoyce Man-Fong Lee
- Daniel Wai-Hung HoDHDaniel Wai-Hung Ho
- Yu-Man TsuiYTYu-Man Tsui
- Lo-Kong ChanLCLo-Kong Chan
- Irene Oi-Lin NgINIrene Oi-Lin Ng
Open Access
- 9 May 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 83 (4) , 735-752
Abstract
Background & Aims: Research on metabolic reprogramming in hepatocellular carcinoma (HCC) has increased; however, studies on the metabolism of glycerolipids or interactions between different pathways remain scarce. Enzymes of glycerol phosphate dehydrogenase (GPD) family, which regulate glycerol-3-phosphate shuttle, link the metabolic processes of glycolysis and glycerolipids. Therefore, we aimed to understand the role and regulation of GPDs in HCC. Approach & Results: We performed transcriptomic analysis on clinical HCC samples from in-house and public cohorts and detected upregulation of glycerol-3-phosphate dehydrogenase 1 like (GPD1L) among GPD family genes in HCC. Further analysis showed that high GPD1L expression was associated with more frequent venous invasion and shorter overall survival. Consistent with these clinical findings, GPD1L knockdown suppressed invasiveness of HCC cells, reduced colony- and sphere-forming abilities, and inhibited stemness gene expression in vitro, while also inhibiting tumor growth and metastasis in vivo. On the other hand, we used mass-spectrometry-based metabolomics to confirm that GPD1L facilitated the biogenesis of the glycerolipid precursor glycerol-3-phosphate (G3P) from dihydroxyacetone phosphate (DHAP). Further untargeted lipidomic analysis revealed that GPD1L supported triacylglycerol synthesis. Additionally, our study identified E74 like E-Twenty-Six transcription factor 1 (ELF1) as a direct activator of GPD1L transcription, binding to the GPD1L promoter to boost its transcription while reducing GPD1L expression when ELF1 levels were lowered. Conclusions: GPD1L is overexpressed in human HCCs and associated with worse clinical outcomes. Aberrant GPD1L expression, driven by ELF1, facilitates conversion of DHAP to G3P conversion to support triacylglycerol synthesis in HCC, promoting tumor growth and metastasis. ExportKeywords
This publication has 47 references indexed in Scilit:
- Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular CarcinomaHepatology, 2020
- Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in CancerCell Metabolism, 2020
- Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid SaturationCell Reports, 2018
- Pigment epithelium-derived factor in lipid metabolic disordersBiomedical Journal, 2018
- Regulation of Hepatic Triacylglycerol Metabolism by CGI-58 Does Not Require ATGL Co-activationCell Reports, 2016
- Antioxidant Role for Lipid Droplets in a Stem Cell Niche of DrosophilaCell, 2015
- The role of glycerol-3-phosphate dehydrogenase 1 in the progression of fatty liver after acute ethanol administration in miceBiochemical and Biophysical Research Communications, 2014
- Cellular Fatty Acid Metabolism and CancerCell Metabolism, 2013
- The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissuesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2013
- Molecular cloning, sequencing and expression of a cDNA encoding a human liver NAD-dependent α-glycerol-3-phosphate dehydrogenaseBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995